SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US Listed > Biotechs >

Icon Plc (ICLR)

ICLR RSS Feed 		Add ICLR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/12/2017 3:15:42 PM - Followers: 1 - Board type: Free - Posts Today: 0

  ICON     

A Symbol Of Excellence

(We are a European (Irish) company and therefore use British English on our website, hence the s usage, and British spelling.)

ICON is a Global Contract Research Organization (CRO). We specialise in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies.

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies.

n a highly fragmented industry, we are one of a small group of organizations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.

ICON Announces the Commencement of Direct Trading on NASDAQ

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, commenced direct trading of ICON ordinary shares on NASDAQ (CUSIP Number G4705A 100) yesterday, 4th February 2013. This follows ICON's withdrawal from the Irish Stock Exchange on the 30th January 2013 and the termination of the ADR programme in accordance with the resolutions approved by the shareholders at the Extraordinary General Meeting of the Company on 17th December 2012.

The information contained in this release is as of 5th February 2013. The statements made in this press release may contain forward-looking statements that involve a number of risks and uncertainties. A description of risks and uncertainties relating to ICON and its business can be found in ICON's Annual Report for the fiscal year ended December 31, 2011 and in the forms filed with the US Securities and Exchange Commission, including the Forms 20-F, F-1, S-8 and F-3. ICON disclaims any intent or obligation to update these forward-looking statements.

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 82 locations in 40 countries and has approximately 9,430 employees. Further information is available at http://www.iconplc.com.

ICON/ICLR-F

ICON
Investor Relations
1-888-381-7923
or
Brendan Brennan
Chief Financial Officer
+ 353 -1-291-2000
or
Sam Farthing
VP Investor Relations
+ 353 -1-291-2000
http://investor.iconplc.com/
ICLR
Current Price
Volume:
Bid Ask Day's Range
ICLR Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
ICLR News: Report of Foreign Issuer (6-k) 06/23/2017 06:05:24 AM
ICLR News: ICON and DIA Amplify Thought Leadership and Debate with DIA Live 2017 06/16/2017 05:00:00 AM
ICLR News: Healthcare Stocks on Investors' Radar -- PAREXEL, IDEXX Labs, ICON PLC, and PRA Health Sciences 06/09/2017 06:50:00 AM
ICLR News: ICON and Regeneron Win Best Partnership in Clinical Research Award from PharmaTimes 05/24/2017 05:00:00 AM
ICLR News: ICON Named by Forbes as One of the Best Employers in America 05/11/2017 06:00:00 AM
PostSubject
#17   ICON is scheduled to report earnings on Thursday ValueInvestor15 02/12/17 03:15:42 PM
#16   ICLR bullish 76.12 stocktrademan 08/10/16 10:17:16 AM
#15   SEC suspension cancelled. IPO$ 10/22/14 12:48:10 PM
#14   ICLR: SEC Admin Proceeding still active: Renee 10/22/14 11:23:36 AM
#13   ICLR SEC Suspension cancelled. Renee 10/22/14 10:06:16 AM
#12   ICLR: SEC Suspension: Renee 10/22/14 09:33:37 AM
#11   $ICLR DD Notes ~ http://www.ddnotesmaker.com/ICLR stocktrademan 09/10/14 01:01:50 PM
#10   News Story johnsyn 03/27/14 07:37:54 PM
#9   http://seekingalpha.com/article/1575362-icon-plc-ordinary-shares-iclr-management johnsyn 07/27/13 07:35:59 AM
#8   http://seekingalpha.com/article/1372991-icon-public-limited-management-discusses johnsyn 04/25/13 08:06:55 PM
#7   6:41 AM ICON plc (ICLR): Q1 EPS of johnsyn 04/25/13 08:16:41 AM
#6   http://www.marketintelligencecenter.com/articles/269311 ICON Plc (ICLR) Market Cap: $1.96 billion johnsyn 04/02/13 01:22:23 PM
#5   ICON Announces Appointment of Professor William Hall to johnsyn 02/22/13 09:41:05 AM
#4   Jeffries raises P/T to $33.50, Raymond James raises johnsyn 02/20/13 03:11:18 PM
#3   ICON To Acquire Clinical Trial Services Division of johnsyn 02/19/13 05:29:42 PM
#2   Cross Country Healthcare Completes Sale of Its Clinical johnsyn 02/19/13 05:28:39 PM
#1   ICON Reports Fourth Quarter 2012 Revenue of $300 johnsyn 02/19/13 05:27:39 PM
PostSubject
© 2017 InvestorsHub.Com, Inc.